Biosimilar matches rituximab in large follicular lymphoma trialSeptember 12, 2017Aggressive Lymphomas
Analysis: Actual cancer drug R&D costs are far less than widely publicized sumSeptember 12, 2017Business of Medicine
ASCO issues guideline on communication with patientsSeptember 11, 2017Patient & Survivor CareBusiness of Medicine
Plerixafor doesn’t overcome HPC failure in R-hyperCVAD for mantle cell lymphomaSeptember 10, 2017Mantle Cell Lymphoma
Sen. Alexander seeks quick, passable steps to stabilize individual marketsSeptember 6, 2017Business of Medicine
Is pain or dependency driving elevated opioid use among long-term cancer survivors?September 6, 2017Patient & Survivor CareHodgkin Lymphoma
Trump administration ends DACA program, stranding medical studentsSeptember 5, 2017Business of Medicine
Pembrolizumab, nivolumab linked to 3% rate of neurologic eventsSeptember 5, 2017Patient & Survivor CareHodgkin Lymphoma
